[Active surveillance in prostate cancer: Assessment of MRI in the selection and follow-up of patients].

CONCLUSION: For patients under AS, mpMRI decreases reclassification rates over time through better initial detection of significant cancers. Its high NPV makes it an efficient monitoring tool to distinguish patients with low risk of reclassification.
LEVEL OF EVIDENCE: 4.
PMID: 29861328 [PubMed - as supplied by publisher]

Source: Progres en Urologie - June 5, 2018 Category: Urology & Nephrology Tags: Prog Urol Source Type: research